In vivo phage display--a discovery tool in molecular biomedicine
- PMID: 23623852
- DOI: 10.1016/j.biotechadv.2013.04.004
In vivo phage display--a discovery tool in molecular biomedicine
Abstract
In vivo phage display is a high-throughput method for identifying target ligands specific for different vascular beds. Targeting is possible due to the heterogeneous expression of receptors and other antigens in a particular vascular bed. Such expression is additionally influenced by the physiological or pathological status of the vasculature. In vivo phage display represents a technique that is usable in both, vascular mapping and targeted drug development. In this review, several important methodological aspects of in vivo phage display experiments are discussed. These include choosing an appropriate phage library, an appropriate animal model and the route of phage library administration. In addition, peptides or antibodies identified by in vivo phage display homing to specific types of vascular beds, including the altered vasculature present in several types of diseases are summarized. Still, confirmation in independent experiments and reproduction of identified sequences are needed for enhancing the clinical applicability of in vivo phage display research.
Keywords: Molecular medicine; Peptide identification; Phage library; Screening; Targeting.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
Vascular-homing peptides for targeted drug delivery and molecular imaging: meeting the clinical challenges.Biochim Biophys Acta. 2014 Aug;1846(1):1-12. doi: 10.1016/j.bbcan.2014.03.004. Epub 2014 Apr 1. Biochim Biophys Acta. 2014. PMID: 24704283 Review.
-
Phage peptide display.Handb Exp Pharmacol. 2008;(185 Pt 2):145-63. doi: 10.1007/978-3-540-77496-9_7. Handb Exp Pharmacol. 2008. PMID: 18626602 Review.
-
Vascular targeting with phage peptide libraries.Q J Nucl Med. 1999 Jun;43(2):159-62. Q J Nucl Med. 1999. PMID: 10429511 Review.
-
A new phage-display tumor-homing peptide fused to antiangiogenic peptide generates a novel bioactive molecule with antimelanoma activity.Mol Cancer Res. 2011 Nov;9(11):1471-8. doi: 10.1158/1541-7786.MCR-10-0501. Epub 2011 Sep 7. Mol Cancer Res. 2011. PMID: 21900362
-
Identification and Characterization of Homing Peptides Using In Vivo Peptide Phage Display.Methods Mol Biol. 2015;1324:205-22. doi: 10.1007/978-1-4939-2806-4_14. Methods Mol Biol. 2015. PMID: 26202272 Review.
Cited by
-
Synthesis of linear and cyclic peptide-PEG-lipids for stabilization and targeting of cationic liposome-DNA complexes.Bioorg Med Chem Lett. 2016 Mar 15;26(6):1618-1623. doi: 10.1016/j.bmcl.2016.01.079. Epub 2016 Feb 4. Bioorg Med Chem Lett. 2016. PMID: 26874401 Free PMC article.
-
Phage Peptide Libraries As a Source of Targeted Ligands.Acta Naturae. 2016 Jan-Mar;8(1):48-57. Acta Naturae. 2016. PMID: 27099784 Free PMC article.
-
Competition of charge-mediated and specific binding by peptide-tagged cationic liposome-DNA nanoparticles in vitro and in vivo.Biomaterials. 2018 Jun;166:52-63. doi: 10.1016/j.biomaterials.2018.02.052. Epub 2018 Mar 2. Biomaterials. 2018. PMID: 29544111 Free PMC article.
-
RNAi therapies: drugging the undruggable.Sci Transl Med. 2014 Jun 11;6(240):240ps7. doi: 10.1126/scitranslmed.3008362. Sci Transl Med. 2014. PMID: 24920658 Free PMC article.
-
Paradigm shift in bacteriophage-mediated delivery of anticancer drugs: from targeted 'magic bullets' to self-navigated 'magic missiles'.Expert Opin Drug Deliv. 2017 Mar;14(3):373-384. doi: 10.1080/17425247.2016.1218463. Epub 2016 Aug 5. Expert Opin Drug Deliv. 2017. PMID: 27466706 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources